Elsevier

Neuroscience

Volume 47, Issue 2, March 1992, Pages 325-332
Neuroscience

Extracellular dopamine in striatum: Influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input

https://doi.org/10.1016/0306-4522(92)90248-ZGet rights and content

Abstract

Microdialysis probes were used to measure dopamine in, and to administer glutamate receptor antagonists and agonists to, the striatum of unanesthetized rats. Antagonists used were: kynurenate, 2-amino-5-phosphonovalerate and 6-cyano-7-nitroquinoxaline-2,3-dione. Agonists used were: N-methyl-d-aspartate and kainate. In some rats an additional dialysis probe was implanted in medial forebrain bundle for infusion of tetrodotoxin (10μM) to block action potential propagation along dopaminergic axons in this pathway. The latter treatment reduced dopamine in striatal dialysate to below detectable levels (<0.5 pg). The quantity of dopamine in striatal dialysate was not reduced by the local application of glutamate receptor antagonists. At lower concentrations, the receptor antagonists failed to alter significantly the quantity of dopamine, whereas the highest concentration of each antagonist increased the amount of dopamine in the dialysate. At the highest concentration tested (0.75 mM or 1.0 mM), as well as at a lower concentration (0.1 mM), 2-amino-5-phosphonovalerate and 6-cyano-7-nitroquinoxaline-2,3-dione blocked the dopamine-releasing effects of exogenously applied N-methyl-d-aspartate (1.0 mM) or kainate (0.1 mM), respectively. Thus, concentrations of glutamate receptor antagonists that produced effective pharmacological blockade of the respective receptors had no effect on the basal amount of dopamine in striatal extracellular fluid. Finally, N-methyl-d-aspartate and kainate produced a significant elevation in extracellular dopamine during the infusion of tetrodotoxin into the medial forebrain bundle, indicating that impulse activity in this pathway is not necessary for dopamine release produced by glutamate receptor agonists.

We conclude that the basal amount of dopamine in striatal dialysate in unanesthetized rats during quiet waking or sleep is determined by the electrophysiological activity of nigrostriatal dopamine neurons. Despite numerous reports that glutamate receptor agonists are able to stimulate dopamine release in striatum, the present data obtained using glutamate receptor antagonists suggest that endogenous glutamate exerts no tonic effect on extracellular dopamine in striatum under these conditions.

References (50)

  • ImperatoA. et al.

    Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely-moving rats

    Brain Res.

    (1990)
  • ImperatoA. et al.

    NMDA receptors andin vivo dopamine release in the nucleus accumbens and caudatus

    Eur. J. Pharmac.

    (1990)
  • KeefeK.A. et al.

    Environmental stress increases extracellular dopamine in striatum of 6-hydroxydopamine-treated rats:in vivo microdialysis studies

    Brain Res.

    (1990)
  • LevielV. et al.

    The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function

    Neuroscience

    (1990)
  • McGeerP.L. et al.

    A glutamatergic corticostriatal path?

    Brain Res.

    (1977)
  • MoghaddamB. et al.

    Do endogenous excitatory amino acids influence striatal dopamine release?

    Brain Res.

    (1991)
  • MoghaddamB. et al.

    Effect ofl-glutamate on the release of striatal dopamine:in vivo dialysis and electrochemical studies

    Brain Res.

    (1990)
  • RobertsP.J. et al.

    Effects ofl-glutamate and related amino acids upon the release of [3H]dopamine from rat striatal slices

    Brain Res.

    (1978)
  • RobinsonT.E. et al.

    Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats

    Brain Res.

    (1988)
  • RomoR. et al.

    In vivo presynaptic control of dopamine release in the cat caudate nucleus—I. Opposite changes in neuronal activity and release evoked from thalamic motor nuclei

    Neuroscience

    (1986)
  • RomoR. et al.

    In vivo presynaptic control of dopamine release in the cat caudate nucleus—III. Further evidence for the implication of corticostriatal glutamatergic neurons

    Neuroscience

    (1986)
  • SandsS.B. et al.

    A quantitative description of excitatory amino acid neurotransmitter responses on cultured embryonicXenopus spinal neurons

    Brain Res.

    (1989)
  • StreckerR.E. et al.

    Substantia nigra dopaminergic activity in behaving cats: effect of arousal on spontaneous discharge and sensory evoked activity

    Brain Res.

    (1985)
  • WesterinkB.H.C. et al.

    Scope and limitations ofin vivo brain dialysis: a comparison of its application to various neurotransmitter systems

    Life Sci.

    (1987)
  • WesterinkB.H.C. et al.

    On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals

    Neurosci. Lett.

    (1989)
  • Cited by (128)

    • Reprint of “Animal models of early-stage Parkinson's disease and acute dopamine deficiency to study compensatory neurodegenerative mechanisms”

      2018, Journal of Neuroscience Methods
      Citation Excerpt :

      In addition, its infusion in the MFB abolished the intrapallidal morphine-induced increase in levels of DA and its metabolites 3,4-dihydroxyphenylacetic (DOPAC) and homovanillic acid (HVA) in the nucleus accumbens (Anagnostakis et al., 1998). A TTX infusion in the MFB has been shown to block the activity of DAergic fibres (Commissiong et al., 1990: 300 nM, 1.5 μl; 1 μl/min) and reduce extracellular DA concentrations in the striatum to undetectable levels (Keefe et al., 1992, 10 μM infusion in MFB for 3 h). The TTX infusion is usually performed via cannula or probe implanted in the MFB, and different studies have reported that the DA level appears to be influenced by the implantation, suggesting that the implantation itself may cause a mechanical lesion that determines the dysfunction of DAergic fibres.

    • The medial forebrain bundle as a deep brain stimulation target for treatment resistant depression: A review of published data

      2015, Progress in Neuro-Psychopharmacology and Biological Psychiatry
      Citation Excerpt :

      Moreover, two other electrophysiological probes have proven that at least three different populations of ventrolateral medullary neurons project to the medial preoptic/anterior hypothalamic area through the MFB (Galati et al., 2010; Kaba et al., 1986). Another preclinical study used a microdialysis probe adding glutamate agonists (N-methyl-d-aspartate and kainate) and antagonists (kynurenate, 2-amino-5-phosphonovalerate and 6-cyano-7-nitroquinoxaline-2,3-dione) to measure their effect on dopamine concentrations in the striatum of rodents (Keefe et al., 1992). During this experimental trial, a tetrodotoxin dialysis probe was implanted in order to block potential propagation of stimulation along the dopaminergic axons within the MFB.

    View all citing articles on Scopus
    View full text